Clinical Trials for Primary Membranous Nephropathy

Find clinical trials for primary membranous nephropathy. Discover research opportunities and treatment options in your area.

17 Active Trials Found

Showing 17 trials on this page

Page 1 of 1

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)

NCT ID: NCT06557265

The clinical trial titled Ntrust-1 is investigating a new treatment called NKX019, which uses special immune cells known as chimeric antigen receptor (CAR) natural killer cells to see if it can hel...

Recruiting

Phase: PHASE1 Type: interventional Locations: Little Rock, Arkansas, United States, Worcester, Massachusetts, United States +15 more

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

NCT ID: NCT05707377

This clinical trial is studying a medication called zanubrutinib to see how safe and effective it is for treating a kidney condition known as primary membranous nephropathy. The trial is divided in...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milwaukee, Wisconsin, United States, Vancouver, British Columbia, Canada +136 more

A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

NCT ID: NCT07029139

This clinical trial is studying a new medicine called JMT601 for adults who have a kidney condition called primary membranous nephropathy (PMN). This condition affects the kidneys’ ability to filte...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

NCT ID: NCT06962800

This clinical trial is designed to learn more about a treatment called felzartamab for adults with primary membranous nephropathy (PMN), a condition where the kidneys become damaged due to the buil...

Recruiting

Phase: PHASE3 Type: interventional Locations: Los Angeles, California, United States, Dallas, Texas, United States

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

NCT ID: NCT05800873

This clinical trial is studying a new medication called EVER001, which is an oral treatment designed to help people with a kidney condition known as primary membranous nephropathy. This condition c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Suzhou, Jiangsu, China, Beijing, , China +17 more

Study of YK012 in Primary Membranous Nephropathy

NCT ID: NCT06982729

This clinical trial is looking at a new treatment called YK012 for people with a kidney condition called primary membranous nephropathy (PMN). The main focus is to see how safe the treatment is, ho...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Study of WAL0921 in Patients With Glomerular Kidney Diseases

NCT ID: NCT06466135

This clinical trial is studying a new treatment called WAL0921 for patients with certain types of kidney diseases, specifically those that affect the filtering units of the kidneys, known as glomer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Westmead, New South Wales, Australia, Derby, , United Kingdom +7 more

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

NCT ID: NCT06470191

This clinical trial is investigating a new treatment called B007 for patients with Primary Membranous Nephropathy, a kidney condition that can cause protein to leak into the urine and lead to serio...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China, Nantong, , China +22 more

A Real World Study About PMN

NCT ID: NCT06893328

This clinical trial is focused on finding the best way to treat a kidney condition called Primary Membranous Nephropathy (PMN). Researchers want to compare two treatment approaches: one that combin...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT ID: NCT05668403

This clinical trial is investigating a new treatment for Primary Membranous Nephropathy, a kidney condition that can lead to serious health issues. Researchers are testing a type of medication call...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China, Zhengzhou, Henan, China +4 more

OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

NCT ID: NCT06781944

The Blossom Study is a clinical trial examining two different treatments for patients with primary membranous nephropathy (pMN), a kidney condition. In this study, researchers will compare the effe...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

NCT ID: NCT06642909

This clinical trial is studying a new treatment called Zuberitamab for patients with primary membranous nephropathy, a condition that affects the kidneys. The goal of the trial is to see how well Z...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

NCT ID: NCT06614985

This clinical trial is looking at a new treatment called Telitacicept for adults with primary membranous nephropathy, a kidney disease that can cause serious problems like swelling and high protein...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei China, China

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

NCT ID: NCT06573411

This clinical trial is studying the effectiveness and safety of a medication called finerenone in patients with a kidney condition known as primary membranous nephropathy (PMN). The researchers wan...

Not yet recruiting

Phase: PHASE4 Type: interventional

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

NCT ID: NCT05696613

This clinical trial is studying a treatment called SNP-ACTH (1-39) Gel for patients with a kidney condition known as Primary Membranous Nephropathy (PMN). The trial is divided into two parts: the f...

Recruiting

Phase: PHASE3 Type: interventional Locations: Charlottesville, Virginia, United States, Iowa City, Iowa, United States +32 more

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

NCT ID: NCT05514015

This clinical trial is studying the effectiveness of a medication called rituximab, either alone or combined with corticosteroids, for treating a kidney condition known as primary membranous nephro...

Recruiting

Phase: PHASE4 Type: interventional Locations: Guangzhou, Guangdong, China

REmission in Membranous Nephropathy International Trial (REMIT)

NCT ID: NCT06120673

The REMIT trial is studying the effectiveness of two different treatments for adults with Primary Membranous Nephropathy (PMN), a kidney condition that can cause significant protein loss in urine a...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Camperdown, New South Wales, Australia, Woolloongabba, Queensland, Australia +13 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions